Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Gastrointest Surg ; 26(6): 1298-1306, 2022 06.
Artículo en Inglés | MEDLINE | ID: mdl-35469036

RESUMEN

BACKGROUND: Ligation of intersphincteric fistula tract (LIFT) is a sphincter-saving procedure used for treatment of complex anal fistula. The current study aimed to assess the outcome of local injection of bone marrow mononuclear cells (BM-MNCs) in conjunction with LIFT as compared to LIFT alone in regards to healing rate, time to healing, and ultimate success rate. METHODS: This was a prospective randomized trial on patients with trans-sphincteric anal fistula. Patients were randomly allocated to one of two equal groups: LIFT and LIFT with BM-MNC injection. The main outcome measures were healing at 10 weeks of follow-up, recurrence after healing, and complications. RESULTS: Seventy patients (48 male and 22 female) of a mean age of 37.9 ± 10.4 years were included. The mean time to complete healing after LIFT + BM-MNCs was significantly shorter than after LIFT alone (20.5 ± 5.2 vs 28.04 ± 5.8 days; P < 0.0001). The ultimate success rates of both groups were similar (LIFT = 60% vs LIFT with BM-MNCs = 68.6%, P = 0.62). There was no significant difference in the mean operation time or complication rate between the two groups. Secondary extension and previous anal surgery were significant independent predictors of failure of healing. CONCLUSION: LIFT combined with BM-MNC injection was associated with a shorter time to complete healing than LIFT alone. However, BM-MNC injection did not have a significant impact on the overall healing and ultimate success rate.


Asunto(s)
Médula Ósea , Fístula Rectal , Adulto , Canal Anal/cirugía , Femenino , Humanos , Inflamación/etiología , Ligadura/métodos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/etiología , Estudios Prospectivos , Fístula Rectal/etiología , Fístula Rectal/cirugía , Recurrencia , Resultado del Tratamiento
2.
Int J Surg ; 11(1): 52-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23187047

RESUMEN

BACKGROUND: Rectal prolapse is a distressing and socially disabling condition. controversy exists regarding the preferred surgical technique for the treatment of complete rectal prolapse. OBJECTIVE: We compared Delorme operation alone or with postanal repair and levatroplasty in treating complete rectal prolapse. METHODS: Consecutive patients treated for rectal prolapse at our colorectal unit were evaluated for inclusion. Participants were randomly allocated to receive Delorme operation only (GI), or Delorme operation with postanal repair and levatorplasty (GII). MAIN OUTCOME MEASURES: The primary outcome measure was recurrence rate; secondary outcomes included improvement of constipation, incontinence, operative time, anal manometery and postoperative complications. RESULTS: Eighty-two consecutive patients with rectal prolapse were randomized. There was a significant difference between the two groups with longer operative time in group II. Recurrence rate after one year was (14.28% in GI, and 2.43% in GII, respectively (P = 0.043). Constipation improved in group I & II but there was a significant difference in constipation scores postoperatively between the two groups. There was improvement in continence mechanism in both groups postoperatively but being higher in group II and this produce a significant statistical difference (0.004). Mean satisfaction score was significantly higher in group II than group I. Both groups succeed to produce a significant change in resting and squeeze pressure before & after the operation. CONCLUSIONS: Delorme operation seems to be an effective procedure for treating complete rectal prolapse especially if combined with postanal repair and levatorplasty. CLINICAL TRIAL REGISTRATION: NCT01656369.


Asunto(s)
Canal Anal/cirugía , Procedimientos Quirúrgicos del Sistema Digestivo/métodos , Prolapso Rectal/cirugía , Adolescente , Adulto , Estreñimiento/cirugía , Femenino , Humanos , Mucosa Intestinal/cirugía , Masculino , Manometría , Persona de Mediana Edad , Presión , Recurrencia , Resultado del Tratamiento , Adulto Joven
3.
J Gastrointest Surg ; 16(10): 1955-62, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22869534

RESUMEN

BACKGROUND: Lateral internal sphincterotomy has been proven highly effective in curing anal fissure but with a high incidence of postoperative incontinence. OBJECTIVE: We compared conventional lateral internal sphincterotomy, V-Y advancement flap, and combined tailored lateral internal sphincterotomy with V-Y advancement flap in treating anal fissure. PATIENTS: Consecutive patients treated for anal fissure at our colorectal unit were evaluated for inclusion. Participants were randomly allocated to receive conventional sphincterotomy (GI), V-Y advancement flap (GII), or combined tailored lateral sphincterotomy with V-Y advancement l flap (GIII). MAIN OUTCOME MEASURES: The primary outcome measure was the incontinence rate; secondary outcomes included healing rate, operative time, anal manometery, and recurrence rate. RESULTS: One hundred fifty patients with chronic anal fissure were randomized. Healing rate after 1 year was 84% in GI, 48% in GII, and 94% in GIII, respectively (P = 0.001). The recurrence rate was 4% in G1, 22% in GII, and 2% in GIII (P = 0.01). Incontinence rate was 14% in GI, 0% in GII, and 2% in GIII (P = 0.03). CONCLUSION: Although all three procedures are simple and easy to perform, tailored lateral internal sphincterotomy with V-YF appears to produce the greatest healing rate, with the fewest complications and less rate of recurrence.


Asunto(s)
Canal Anal/cirugía , Incontinencia Fecal/prevención & control , Fisura Anal/cirugía , Procedimientos de Cirugía Plástica/métodos , Complicaciones Posoperatorias/prevención & control , Colgajos Quirúrgicos , Adolescente , Adulto , Análisis de Varianza , Enfermedad Crónica , Incontinencia Fecal/etiología , Femenino , Humanos , Análisis de Intención de Tratar , Masculino , Persona de Mediana Edad , Satisfacción del Paciente/estadística & datos numéricos , Estudios Prospectivos , Calidad de Vida , Recurrencia , Resultado del Tratamiento , Cicatrización de Heridas , Adulto Joven
4.
Int J Surg ; 7(2): 126-9, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19138577

RESUMEN

BACKGROUND: This study was conducted to elucidate the prevalence of Helicobacter pylori in patients with a perforated duodenal ulcer and to determine whether eradication of H. pylori prevent ulcer recurrence following simple repair of the perforation. PATIENTS AND METHOD: Eighty-three patients with perforated duodenal ulcer (68 males); mean age was 47.8 years+/-7.2. Antral mucosal biopsies (to determine the status of HP by rapid urease test, culture and histological examination/staining) were obtained during laparotomy by passing a biopsy forceps through the perforation site. H. pylori positive patients who had undergone patch repair were randomized into the eradication group who received amoxicillin, metranidazole plus omperazole and the control group was given omeprazole alone. Follow-up endoscopy and antral biopsies were performed at 8 weeks, 16 weeks and 1 year to show ulcer healing and determine H. pylori state. RESULTS: Of 77 patients in the study, 65 patients (84.8%) had H. pylori. These patients were randomly divided into the triple therapy group (34 patients) and the control group (31 patients). Eradication of H. pylori was significantly higher in the triple therapy group than the control group and initial ulcer healing was significantly better in the eradication group. After 1 year, ulcer recurrence was (6.1%) in the eradication group vs. (29.6%) in the control group (P=0.001). CONCLUSION: H. pylori was present in a high proportion of patients with duodenal ulcer perforation. Eradication of H. pylori after simple closure of a perforated duodenal ulcer reduced the incidence of recurrent ulcer.


Asunto(s)
Antiinfecciosos/uso terapéutico , Antiulcerosos/uso terapéutico , Úlcera Duodenal/cirugía , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Úlcera Péptica Perforada/cirugía , Adulto , Amoxicilina/uso terapéutico , Quimioterapia Combinada , Úlcera Duodenal/microbiología , Femenino , Infecciones por Helicobacter/epidemiología , Humanos , Masculino , Metronidazol/uso terapéutico , Persona de Mediana Edad , Omeprazol/uso terapéutico , Úlcera Péptica Perforada/microbiología , Prevalencia , Prevención Secundaria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...